Raphael Pharmaceutical (RAPH) Other Accumulated Expenses (2025)

Raphael Pharmaceutical has disclosed Other Accumulated Expenses across 1 years of filings, most recently posting $297700.0 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses changed N/A year-over-year to $297700.0; the TTM figure through Dec 2025 stood at $297700.0 (changed N/A YoY), while the FY2025 annual figure was $297700.0, changed N/A from the prior year.
• Other Accumulated Expenses came in at $297700.0 for Q4 2025 at Raphael Pharmaceutical.
• In the past five years, Other Accumulated Expenses ranged from a high of $297700.0 in Q4 2025 to a low of $297700.0 in Q4 2025.